What is SAGA Diagnostics?
SAGA Diagnostics AB operates at the intersection of biotechnology and clinical oncology, specializing in highly sensitive molecular genetic testing. The company provides essential tools for both tissue-based analysis and non-invasive liquid biopsies, enabling clinicians to monitor disease progression with unprecedented accuracy. By focusing on personalized medicine, SAGA Diagnostics addresses a critical gap in cancer care, offering actionable insights that facilitate more effective, data-driven treatment protocols for patients worldwide. Their proprietary technology platform is designed to detect minimal residual disease, positioning the firm as a leader in the next generation of diagnostic monitoring solutions.
How much funding has SAGA Diagnostics raised?
SAGA Diagnostics has raised a total of $12.5M across 1 funding round:
Series A
$12.5M
Series A (2021): $12.5M with participation from Segulah Medical Acceleration and Hadean Ventures
Key Investors in SAGA Diagnostics
Segulah Medical Acceleration
A specialized investment firm focused on accelerating the growth of innovative medical technology companies through strategic capital and operational expertise.
Hadean Ventures
A prominent venture capital firm dedicated to backing early-to-growth stage life science companies that demonstrate significant potential for clinical impact.
What's next for SAGA Diagnostics?
With this major strategic investment, SAGA Diagnostics is poised to scale its operational capabilities and broaden its clinical validation studies. The company is expected to prioritize the expansion of its liquid biopsy portfolio, aiming to integrate its diagnostic solutions into standard oncology workflows. As the market for personalized cancer care continues to mature, SAGA's focus on high-sensitivity detection will likely serve as a key differentiator, attracting further interest from institutional partners and healthcare providers seeking to improve patient outcomes through early and precise disease intervention.
See full SAGA Diagnostics company page
